14152 Video of New Frontiers in Pancreatic Cancer Research
This educational activity is designed to incorporate evidence-based pathophysiology, diagnosis, and/or treatment of surgical disorders into clinical practice. Speakers will utilize departmental quality improvement data, M&M data, and patient safety data to improve outcomes of surgical disease and other aspects of surgical patients’ general health. Evidence-based date regarding the changing aspects/newer approaches to surgical disease will be analyzed, and critical issues related to surgery within the broader scope of American health care will be discussed.
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
General Surgeons, Physician Assistants, Allied Health Care Professionals
- Compare the differences in clinical outcomes between surgery-first vs. neoadjuvant treatment strategies
- Discuss the rationale for tumor-profile directed therapy in pancreatic cancer
Susan Tsai, MD, MHS, Assistant Professor, Division of Surgical Oncology at the Medical College of Wisconsin
All persons in control of content have NO relevant financial relationships to disclose.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.